Abstract
Cases reported as loss of efficacy (secondary failure) of carbamazepine (CBZ) for epilepsy were analysed to determine the cause. In these cases, seizures previously controlled with CBZ, recurred or increased in frequency. The following causes were identified in 131 cases where adequate information was available: use for types of epilepsy where this drug is not recommended, lowering of the blood levels of the drug on switching over from branded to a generic CBZ, change in the galenic form, drug interactions, progression of the underlying brain pathology such as a brain tumor, and unexplained increase in the blood levels of the drug. In cases where the increase in seizures was transient no special measures or changes in therapy were required. Unexplained failure occurred only in seven cases (5.3%). Based on this information, a flow chart was designed to evaluate such a problem step by step and to take appropriate measures. Only when true therapeutic failure is identified, should another antiepileptic drug be substituted for CBZ. Similar approach can be used for other antiepileptic drugs.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Dhuna A., Pascual-Leone A., Talwar D. Exacerbation of partial seizures and onset of nonepileptic myoclonus with carbamazepine. Epilepsia. 1991 Mar-Apr;32(2):275–278. doi: 10.1111/j.1528-1157.1991.tb05255.x. [DOI] [PubMed] [Google Scholar]
- Horn C. S., Ater S. B., Hurst D. L. Carbamazepine-exacerbated epilepsy in children and adolescents. Pediatr Neurol. 1986 Nov-Dec;2(6):340–345. doi: 10.1016/0887-8994(86)90074-3. [DOI] [PubMed] [Google Scholar]
- Sachdeo R. C., Belendiuk G. Generic versus branded carbamazepine. Lancet. 1987 Jun 20;1(8547):1432–1432. doi: 10.1016/s0140-6736(87)90619-2. [DOI] [PubMed] [Google Scholar]
- Shields W. D., Saslow E. Myoclonic, atonic, and absence seizures following institution of carbamazepine therapy in children. Neurology. 1983 Nov;33(11):1487–1489. doi: 10.1212/wnl.33.11.1487. [DOI] [PubMed] [Google Scholar]
- Snead O. C., 3rd, Hosey L. C. Exacerbation of seizures in children by carbamazepine. N Engl J Med. 1985 Oct 10;313(15):916–921. doi: 10.1056/NEJM198510103131503. [DOI] [PubMed] [Google Scholar]
- Troupin A. S., Ojemann L. M. Paradoxical intoxication--a complication of anticonvulsant administration. Epilepsia. 1975 Dec;16(5):753–758. doi: 10.1111/j.1528-1157.1975.tb04761.x. [DOI] [PubMed] [Google Scholar]
- Weiss S. R., Post R. M. Development and reversal of contingent inefficacy and tolerance to the anticonvulsant effects of carbamazepine. Epilepsia. 1991 Jan-Feb;32(1):140–145. doi: 10.1111/j.1528-1157.1991.tb05626.x. [DOI] [PubMed] [Google Scholar]